- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01608425
Ulcer Monitoring in Diabetes Mellitus (Telesaar)
Impact Assessment by Introducing Telemedicine Consultations for Treatment of Diabetic Patients With Foot Ulcers in Region of Southern Denmark - Randomized Prospective Study
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Through randomized and prospective studies the project will show whether a telemedicine approach to wound care can be used as an alternative to traditional attendance at a wound clinic and document whether this consultation form provides a greater patient-satisfaction and cost savings. The project will document that telemedicine is equivalent to conventional outpatient attendance from a therapeutic aspect in terms of number of hospitalizations, number of extra controls, acute interventions and wound healing.
The project is also investigating the extent of time spent on the personnel side using telemedicine consultations compared with conventional outpatient appearances.
Studietype
Inschrijving (Verwacht)
Fase
- Fase 2
Contacten en locaties
Studie Locaties
-
-
Region of Southern Denmark
-
Esbjerg, Region of Southern Denmark, Denemarken, 6700
- Werving
- South-west Hospital
-
Kolding, Region of Southern Denmark, Denemarken, 6000
- Werving
- Lillebaelt Hospital
-
Odense, Region of Southern Denmark, Denemarken, 5000
- Werving
- Odense University Hospital
-
Soenderborg, Region of Southern Denmark, Denemarken, 6400
- Werving
- Hospital South Jutland
-
Svendborg, Region of Southern Denmark, Denemarken, 5700
- Werving
- Svendborg Hospital
-
Vejle, Region of Southern Denmark, Denemarken, 7100
- Werving
- Hospital Lillebaelt
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Having diabetic foot ulcer
- Referred for out-patient clinic treatment by general practitioner
- Referred for out-patient clinic treatment by a surgical department
- Living in Region of Southern Denmark
Exclusion Criteria:
- Psychiatric disorder
- Dementia
- Chronic alcohol abuse which can affect compliance
- Other disorder then diabetes mellitus that have caused foot ulcer (rheumatoid arthritis or arthritis urica)
- Serious kidney disease which requires dialysis
- Previous foot ulcer - which was part of the study
- Expected healing within 2-4 weeks where only one control (final) is expected
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Control
Control group.
Regular treatment.
|
|
|
Experimenteel: Diabetes ulcer monitoring
Receives a telemedicine intervention: Diabetes ulcer monitoring.
|
Replacing 2 out of 3 patient visits to out-patient clinic at hospital with treatment at home from visiting nurse and telemedicine consultations with the specialist doctor.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Admissions to hospital
Tijdsspanne: from time of inclusion until treatment completed, assessed up to 52 weeks
|
The number of admissions, incl, beddays, to hospital relating to ulcer treatment for each randomised patient during the treatment period.
|
from time of inclusion until treatment completed, assessed up to 52 weeks
|
|
Surgical procedures
Tijdsspanne: from time of inclusion until completed treatment, assessed up to 52 weeks
|
The number of surgical procedures (incl.
amputations) performed at hospital in realtion to the ulcer during the treatment period.
|
from time of inclusion until completed treatment, assessed up to 52 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Ulcer healing
Tijdsspanne: Progress is measured at minimum every 4 weeks during treatment period, assessed up to 52 weeks
|
The time from inclusion and start of treatment until ulcer is healed and treatment is stopped.
|
Progress is measured at minimum every 4 weeks during treatment period, assessed up to 52 weeks
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Benjamin S. Rasmussen, MD, Odense University Hospital
- Hoofdonderzoeker: Johnny Froekjaer, MD, Odense University Hospital
- Studie stoel: Knud B. Yderstraede, MD, Odense University Hospital
Publicaties en nuttige links
Algemene publicaties
- Fasterholdt I, Gerstrom M, Rasmussen BSB, Yderstraede KB, Kidholm K, Pedersen KM. Cost-effectiveness of telemonitoring of diabetic foot ulcer patients. Health Informatics J. 2018 Sep;24(3):245-258. doi: 10.1177/1460458216663026. Epub 2016 Sep 16.
- Rasmussen BS, Froekjaer J, Bjerregaard MR, Lauritsen J, Hangaard J, Henriksen CW, Halekoh U, Yderstraede KB. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care. 2015 Sep;38(9):1723-9. doi: 10.2337/dc15-0332. Epub 2015 Jun 26.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Telesaar RH_3
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .